|
HS Code |
954862 |
| Organism Name | Vibrio chagasii |
| Taxonomy | Bacteria; Gammaproteobacteria; Vibrionales; Vibrionaceae; Vibrio |
| Cell Shape | Curved rod |
| Gram Stain | Gram-negative |
| Oxygen Requirement | Facultative anaerobe |
| Motility | Motile with polar flagella |
| Optimum Temperature | 20-30°C |
| Salinity Tolerance | Marine; requires NaCl for growth |
| Pathogenicity | Opportunistic pathogen in marine organisms |
| Habitat | Marine environments (coastal waters, sediment) |
| Colony Appearance | Smooth, creamy, round colonies on marine agar |
| Bioluminescence | Non-bioluminescent |
| Catalase Activity | Catalase positive |
| Oxidase Activity | Oxidase positive |
| Industrial Application | Used in research on marine bacteria and aquaculture |
As an accredited Vibrio Chagasii factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | White, sterile plastic vial labeled "Vibrio chagasii – 1g lyophilized culture," includes hazard symbol, lot number, and storage instructions. |
| Shipping | Vibrio chagasii is shipped as a viable culture in a secure, leak-proof container with absorbent material, following all biosafety and regulatory guidelines. The package is labeled appropriately for biological materials and kept at controlled temperatures, typically shipped via overnight or express courier to ensure organism viability and safe arrival. |
| Storage | **Vibrio chagasii** cultures should be stored in tightly sealed vials at -80°C for long-term preservation, typically in marine broth with 15-20% glycerol as a cryoprotectant. For short-term storage, maintain at 4°C on marine agar slants. Ensure proper labeling and follow biosafety protocols, as Vibrio species may be opportunistic pathogens. Avoid repeated freeze-thaw cycles. |
|
Purity 99%: Vibrio Chagasii with 99% purity is used in marine aquaculture bioaugmentation, where it enhances nitrogen removal efficiency. Cell concentration 1x10^8 CFU/mL: Vibrio Chagasii at 1x10^8 CFU/mL is used in shrimp larviculture systems, where it improves larval survival rates. Stability temperature 4°C: Vibrio Chagasii maintained at 4°C is used in refrigerated probiotic formulations, where it preserves cell viability during storage. Particle size <2 µm: Vibrio Chagasii with particle size below 2 µm is used in water treatment bioreactors, where it achieves rapid bacterial dispersion. pH tolerance range 6.5–8.5: Vibrio Chagasii with pH tolerance of 6.5–8.5 is used in pond water conditioning, where it maintains metabolic activity under fluctuating environmental conditions. Salinity tolerance up to 35 ppt: Vibrio Chagasii tolerant up to 35 ppt salinity is used in high-salinity aquaculture environments, where it supports robust microbial community establishment. Viable count ≥90%: Vibrio Chagasii with a viable count greater than or equal to 90% is used in live feed augmentation, where it maximizes probiotic delivery efficacy. Endotoxin level <0.1 EU/mL: Vibrio Chagasii with endotoxin levels below 0.1 EU/mL is used in sensitive hatchery applications, where it minimizes inflammatory responses in aquatic species. Genetic stability >95% over 6 months: Vibrio Chagasii with over 95% genetic stability for 6 months is used in long-term bioreactor operations, where it ensures consistent metabolic function. Optical density OD600 1.2: Vibrio Chagasii at an OD600 of 1.2 is used in laboratory assay calibrations, where it provides standardized cell quantification. |
Competitive Vibrio Chagasii prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615365186327 or mail to admin@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8615365186327
Email: admin@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
As a manufacturer working day in and day out with bacterial cultures, we see firsthand how the requirements for marine microbiology tools have evolved. Consumption of marine Vibrio strains has increased, driven by the growing emphasis on marine ecosystem health, food safety, and aquatic disease management. Among the species we cultivate, Vibrio chagasii draws strong interest from research institutions and corporate labs alike. There are good reasons for that. Our production is guided by detailed feedback from end-users, who often tell us a few distinguishing features make all the difference out in the field or under the hood of a laboratory.
Let’s get specific. Vibrio chagasii is a marine Gram-negative bacterium, originally isolated from seawater and bivalve mollusks. Unlike certain Vibrio cousins, it stands out for its relatively broad host range and its ability to adapt to a variety of saline waters. While some Vibrio species are highly host-specific, V. chagasii is found both in association with shellfish and in open marine waters, giving researchers a dependable marker for environmental studies.
Our strains are available as pure cultures, preserved by lyophilization or cryopreservation to maintain genetic integrity and viability. In culturing, we focus on standardized conditions, using marine agar and broth with defined salinities, reflecting the bacterium’s ecological background. This matters because clients need cultures that behave predictably in both baseline and experimental settings. Irregular trace element or carbon source compositions often hamper less carefully produced lines from other suppliers. Regular feedback from researchers working on bivalve aquaculture or water quality monitoring has pushed us to fine-tune our methods, ensuring strains remain highly viable even after extended storage.
Decisions we make aren’t distanced from practical challenges. Marine Vibrio species like Vibrio chagasii occasionally get sidelined in favor of flashier pathogens like V. vulnificus or V. parahaemolyticus. Those colleagues get a lot of press, but enforcement agencies and food producers still want dependable negative controls or background flora strains for their validation work. We’ve seen this in requests for Vibrio chagasii to be included in bioassay panels, especially where endemic bivalve diseases are under investigation.
Researchers often comment on the consistency of our cultures, especially compared with imported materials handled by brokers who rarely see the inside of a lab. Being directly responsible for strain preservation, periodic genetic verification, and the actual logistics of shipping live cultures, we hold ourselves to a standard that comes with knowing the work can’t stop for an unreliable source.
We’ve received detailed reports from laboratories using Vibrio chagasii in water quality screenings, challenge tests with shellfish, and broad marine microbial surveys. Beyond mere survival, clients report reliable colony morphology—typically smooth, off-white, convex when plated on thiosulfate-citrate-bile salts-sucrose (TCBS) agar. Colony formation occurs between 20–30°C with moderate salt, a useful trait in both ambient seawater testing and controlled bench experiments. Our team constantly records morphological and biochemical properties as part of quality control; the stable fermentation profile over repeated subcultures reassures researchers who track subtle variations from batch to batch.
Understanding the difference between strain models matters. Researchers looking for challenge strains mention that Vibrio chagasii—unlike more virulent pathogens—offers a representative background isolate. The gentler pathogenicity makes it suitable for co-infection assays that mimic natural bivalve exposures. Our most requested model, the environmental isolate, is characterized by genetic barcoding. Clients concerned about precise strain identity often request whole-genome sequencing; we work with state-accredited labs to ensure strain authentication, providing the necessary peace of mind for regulatory and publication requirements.
Plenty of researchers ask what sets Vibrio chagasii apart from staple strains like V. fischeri or V. harveyi. V. chagasii usually doesn’t bioluminesce—an easy distinction from V. fischeri—and often displays more robust growth in fluctuating salinity. We see field teams in coastal monitoring choosing it as a stability check for sample integrity, precisely because the species grows reliable lawns over a wider salinity and temperature range.
Much of our direct communication with universities reveals that Vibrio chagasii rarely produces the dramatic hemolysis seen with more pathogenic strains, so it gets the nod for aquaculture risk assessments where a baseline is needed. Our production processes steer clear of high-toxin strains, reflecting lab demand for safety and consistency. The request volume for this species has led us to further invest in equipment for rapid and sterile handling, preventing batch cross-contamination and preserving strain identity.
Although Vibrio chagasii isn’t notorious for severe outbreaks, the growing body of evidence points to its minor role in shellfish diseases and as an indicator of environmental transformation. Commercial hatcheries investigating unexplained bivalve mortalities often screen for Vibrio species diversity before jumping to blame headline pathogens. From our vantage point, Vibrio chagasii typically signals shifts in the microbe community composition or subtle environmental disturbances—often from rapid changes in water quality, salinity, or temperature.
We’ve supported numerous field studies by custom-cultivating batches for environmental DNA (eDNA) spike-in controls. Because we cultivate directly, without middlemen rebranding someone else’s material, our batch documentation tracks facility conditions, dates, and source for each culture. This traceability makes our cultures a go-to for agencies developing or validating new qPCR assays for Vibrio genus detection. Our technical team fields requests for technical data on strain stability and environmental persistence, with datasets that reflect years of batch testing.
Organizational risk comes up in discussions about supply reliability. Traders, resellers, and distributors often scramble in peak demand periods, leading to culture delays or strain mislabeling. Because we handle propagation and packaging on-site, there’s a single point of accountability. Researchers relying on seasonal or time-sensitive field sampling projects often note that predictable shipment schedules and reliable cold chain packaging make or break their projects. Clients in remote locations, working without advanced freezing systems, lean on us for lyophilized formats that reconstitute into viable colonies with high success rates.
Feedback from commercial mussel farms and research consortia points to the reassurance that sourcing directly from the primary manufacturer brings. Our documentation covers critical control points in the propagation process, ensuring shipment of only verified, actively growing cultures to users. Many third-party providers simply don’t have the infrastructure to support this, resulting in loss of viability on arrival. We’ve spent years improving our batch preparation—switching up marine broth components, refining sterilization cycles, tweaking incubation periods—until repeatable outcomes became the norm.
Our daily workflow includes troubleshooting: adapting to unexpected drop-offs in batch yields, retracing steps when a client highlights unexpected morphotypes, and supporting ongoing research with new subtypes. Lessons come quickly in live bacterial culture production. One challenge we see often is the subtle genetic drift that sneaks in during multiple batch expansions. We rotate master stocks and limit subculture generations, tracking each lineage with internal barcoding so newer batches don’t veer away from original properties. No amount of processing downstream can replace careful tracking at every step of the pipeline.
Teaching new team members, we share the reality that not all Vibrio species behave the same in production. Vibrio chagasii responds differently to marine broth prepared with various ocean salts. We’ve learned which batches of commercial sea salt yield the most reliable colony morphologies, rejecting lots that introduce unwanted variability. Regular liaison with field ecologists and aquaculture pathologists ensures our culturing keeps pace with real-world organism dynamics in target habitats.
Demands change—what matters in food safety oversight one year, may shift to disease ecology or biotechnology the next. Clients often call not just for clean cultures, but for new application support. One example: in the past several years, studies investigating microbiomes of marine invertebrates required us to deliver Vibrio chagasii as part of mixed community challenges, testing resilience of native gut flora to Vibrio exposure.
Industry standardization forces us to constantly reassess our control protocols. Labs relying on stable reference strains have sometimes flagged microevolutionary drift in Vibrio chagasii if handled sloppily. We keep weekly records and batch logs so users track what they’ve received against historical data. This ongoing feedback loop builds a culture of mutual trust; researchers feel confident submitting methods sections to journals, while our staff takes pride in seeing their attention to detail reflected in published results.
Producing live bacterial cultures at scale comes with obvious and hidden headaches. Some strains, including Vibrio chagasii, have shown variable oxygen requirements or shifts in pigment production, especially with small tweaks in growth media. We’ve devoted extensive time to setting up parallel culture chambers, using different oxygenation and salinity regimens, logging subtle impacts on growth dynamics and colony appearance. Clients aiming to reproduce downstream infection models or stability experiments benefit from our open-door data policy: we share what works, what doesn’t, and why.
Shipping sensitive cultures anywhere, let alone across borders, invites trouble from customs delays and temperature swings. Having learned from unpleasant near-losses, we’ve implemented redundancies: robust cold-chain containers, double-layer packaging, time-tested desiccants, and verified courier routes screened for temperature reliability. We learned early that cost-cutting couriers lead to more ruined batches than they save in expense, so we’ve prioritized long-term partnerships with specialized couriers.
Technical issues aside, honest conversations with clients frequently shape our priorities. Environmental labs risk running out of viable controls in the middle of survey season; by running extra production batches outsized to anticipated orders, we aim to bridge the gap. Researchers focused on field work, without fallback to substitute species, can’t afford delivery hiccups or misidentified strains. These realities keep us focused on the needs of scientists and technicians through each production cycle.
Beyond research, regulatory frameworks increasingly reference Vibrio spp. as key indicators in seafood safety. Vibrio chagasii, as a non-primary pathogen, provides utility in simulating environmental baselines in shellfish monitoring, helping distinguish routine background occurrences from exceptional shifts. We’ve seen aquaculture consultants add V. chagasii to testing regimes as an early-warning proxy for more dangerous Vibrio blooms. Because its identification is less likely to trigger food safety alarms, it serves as a consistent indicator without causing unnecessary market disruptions.
For biotechnological applications, genetic stability and consistent metabolic outputs matter. Vibrio chagasii lends itself to controlled studies on bacterial ecology, quorum sensing, and marine symbioses. Our feedback loops with technical teams shaping the next generation of detection kits push us to keep pace with project specifications and emerging regulatory changes. We frequently test our strains as part of multi-species consortia, helping partners refine new formulations for probiotics or experimental bioremediation approaches.
Building a reliable production pipeline rarely follows a straight line. Years of process refinement—the switch from outdated glass vials to modern cryovials, investing in rapid-detection molecular tools for contamination screening, adding incremental quality checks at every stage—have been driven by daily troubleshooting, not just regulatory obligation. We field requests for strain authentication more frequently now, a sign the industry expects more transparency and control than in years past.
We remain vigilant about supply chain disruptions. A delay in agar shipments or a failed sterilizer cycle can put entire production slots at risk. To cope, we keep buffer stocks and backup equipment. These measures, born from actual production snags, ensure our partners in research and industry get uninterrupted access to the strains they depend on.
A unique advantage to buying from a manufacturer is continuous communication. Our teams take calls and answer emails from lab technicians, principal investigators, and field workers needing troubleshooting or insight. We log recurring questions and update written protocols, sharing improvements immediately with our customers. Hearing about how Vibrio chagasii performs in exotic field settings, on different continents, and in new experimental formats, gives us insights impossible to gain through intermediaries.
We believe that culture production doesn’t end at shipment. By tracing each lot, recording growth parameters, and staying in touch long after delivery, we create a feedback-driven system. This cycle keeps our practices sharp and preserves user trust. Every new challenge met in the field sharpens our edge as direct partners with the community we serve.
Real-world science relies on traceable, reliable, and consistent biological materials. We invest not only in clean facilities, vigilant staff, and rigorous testing, but also in the open partnerships that undergird successful research and production projects. Vibrio chagasii may be just one tool in a vast set of marine Vibrio options, but our hands-on manufacturing experience makes a difference for those who depend on results that mirror real marine conditions and remain consistent across projects and through time.
By producing, verifying, and delivering cultures ourselves, we ensure that each batch not only enters research pipelines with its original traits intact, but also elevates the reliability of science and commercial marine work. We view each culture as a partner in discovery, providing the foundation so that every project can stand on the strength of proven, field-ready organisms.